MedicinePOM

Ixekizumab

An injectable antibody (IL-17A blocker) for psoriasis and inflammatory spine and joint disease.

Clinical information

Common uses

moderate-to-severe plaque psoriasis (age 6+)
psoriatic arthritis
ankylosing spondylitis
non-radiographic axial spondyloarthritis

Common side effects

injection site reactions
upper respiratory tract infections
feeling sick
fungal (tinea) skin infections

Cautions

serious infections can occur — seek advice for infection symptoms
TB check before starting
can trigger or worsen inflammatory bowel disease
avoid live vaccines

Interactions

live vaccines (avoid)

Pregnancy: insufficient human data

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Taltz (ixekizumab) label, setid ac96658a-d7dc-4c7c-8928-2adcdf4318b2 (accessed 2026-08-16)

Approved brands & formulations1

Brand name	Dosage form	Strength	Importer	Category
Ixekizumab	Parenteral ( Injection )	80mg	—	POM